首页> 外文期刊>Surgical Endoscopy >Effectiveness for pain after laparoscopic cholecystectomy of 0.5% bupivacaine-soaked Tabotamp placed in the gallbladder bed: a prospective, randomized, clinical trial.
【24h】

Effectiveness for pain after laparoscopic cholecystectomy of 0.5% bupivacaine-soaked Tabotamp placed in the gallbladder bed: a prospective, randomized, clinical trial.

机译:腹腔镜胆囊切除术后将0.5%布比卡因浸泡的Tabotamp置于胆囊床中对疼痛的有效性:一项前瞻性,随机,临床试验。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND: Some scientific studies, with controversial results, have evaluated the efficacy in reducing pain of some different local anesthetic molecules, which were administered at different dosages and in different ways. The primary goal of this randomized, controlled, prospective study (Clinical Trials.gov ID NCT00599144) was to assess the effectiveness of 0.5% bupivacaine for pain control after video-laparoscopic cholecystectomy at its optimal dosage of 2 mg/kg infiltrated in the muscular fasciae of the trocars, or positioned in the gallbladder soaking a sheet of regenerated oxidized cellulose (Tabotamp). METHODS: A total of 45 patients underwent elective video-laparoscopic cholecystectomy. They were randomized in three groups each made of 15 patients: group A (bupivacaine-soaked Tabotamp positioned in the gallbladder bed), group B (bupivacaine infiltrated in the muscular fasciae of the trocars' seat), group C (control group, not using local anesthetic). Six and twenty-four hours after the intervention, the nature of the pain and its intensity were recorded with the use of a Visual Analogue Scale (VAS). RESULTS: Six hours after the intervention, VAS average was 29.6 +/- 10.92 for group A, 25.86 +/- 16.06 for group B, and 36.13 +/- 16.62 for group C. At 24 h, we recorded 19.26 +/- 15.81, 18.53 +/- 12.3, and 20.46 +/- 20.08 for groups A, B, and C, respectively (p > 0.05). Comparing groups A and B between them and with the control group at 6 and 24 h, we deduced how only the first group showed a statistically significant advantage (p < 0.05) in reducing visceral and shoulder pain compared with the two other groups. Wound infiltration resulted in being statistically favorable in reducing parietal pain only when compared with Group A. For groups A and B, bupivacaine significantly reduced the use of postoperative pain killers. CONCLUSION: Bupivacaine, either infiltrated in trocars' wounds or kept soaked in a regenerated oxidized cellulose sheet positioned in the gallbladder bed, although safe and not economically demanding, can increase postoperative comfort.
机译:背景:一些科学研究(具有争议的结果)评估了减轻某些不同局部麻醉分子疼痛的功效,这些局部麻醉剂以不同的剂量和方式给药。这项随机,对照,前瞻性研究(Clinical Trials.gov ID NCT00599144)的主要目标是评估在腹腔镜胆囊切除术中以0.5 mg / kg的最佳剂量浸润在肌筋膜中的0.5%布比卡因对疼痛控制的有效性。或将其放置在胆囊中,浸泡一片再生的氧化纤维素(Tabotamp)。方法:共有45例患者接受了择期电视腹腔镜胆囊切除术。他们被随机分为三组,每组15名患者:A组(布比卡因浸泡在胆囊床中的Tabotamp),B组(布比卡因浸入套管针的肌肉筋膜),C组(对照组,不使用局部麻醉药)。干预后六到二十四小时,使用视觉模拟量表(VAS)记录疼痛的性质及其强度。结果:干预后六个小时,A组的VAS平均为29.6 +/- 10.92,B组为25.86 +/- 16.06,C组为36.13 +/- 16.62。在24 h时,我们的记录为19.26 +/- 15.81 A,B和C组分别为18.53 +/- 12.3和20.46 +/- 20.08(p> 0.05)。将A组和B组与对照组和第6组和第24组进行比较,我们推论出只有第一组与其他两组相比在减少内脏和肩部疼痛方面具有统计学上的显着优势(p <0.05)。与A组相比,伤口浸润仅在统计学上有利于减轻壁面疼痛。对于A组和B组,布比卡因可显着减少术后止痛药的使用。结论:布比卡因虽然浸透在胆囊的伤口中或浸泡在位于胆囊床的再生氧化纤维素片中,但安全且对经济要求不高,但可以提高术后舒适度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号